Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Intangible assets $ 3,549,427 $ 3,549,427
Goodwill and Intangible Asset Impairment 0 0
Research and Development Expense 690,937 916,249
Uninsured cash balances 35,000,000 $ 1,912,000
Cell In A Box [Member]    
Intangible assets 1,549,427  
Diabetes License [Member]    
Intangible assets $ 2,000,000  
SG Austria [Member]    
Percentage investment in SG Austria 14.30%